Skip to content
Tech Insights Blog

Zimbabwe Turns Down ‘One-Sided’ US Health Aid Deal Over Data Concerns

Health funding illustration
The proposed US funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a substantial American health deal worth $367m (£272m) spanning five years over the United States' demand for confidential biological samples.

The decision was revealed following a official document dated December was leaked, which showed President Emmerson Mnangagwa deemed the arrangement was "lopsided".

A government spokesperson later clarified that the United States was seeking biological samples for research and commercial gain while was unwilling to guarantee the resulting advantages from any future treatments.

"We must now begin the difficult and regrettable task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged further negotiations to reach a agreement agreeable to both sides so the nation's vital HIV treatment initiative can be sustained.

Wider Background

Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a court blocked a similar deal with the US after concerns were filed about the security of citizens' health data.

Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had managed aid for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government deals to boost transparency and responsibility.

Based on statements, Sixteen nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in new funding.

Specifics of the Declined Agreement

This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment via American-funded programmes," the Ambassador commented.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to surrender its genetic material and health information indefinitely, without any corresponding promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our population if a future health crisis arise."

National Interest and Global Health

He also said that the US's withdrawal from the global health body and its push of bilateral deals were upending structures previously established through the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.

"This framework is intended to guarantee that when a nation provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

These objections over the US deal "must not be interpreted as hostility towards the US," he added.

"We are open to ongoing discussions with our US partners on how subsequent co-operation could be structured in a manner that honours the independence and dignity of each country."

Health Experts Reaction

A leading public health body said it understood the official position, but urged that talks should continue given that a large portion of the nation's Aids initiatives relied on external financing.

"Where technical issues arise, including those relating to information security or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it said.

This impasse highlights the continuing challenges between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.

About the author

Rick Steele

A seasoned software engineer and tech writer with over a decade of experience in AI development and digital transformation strategies.

Tech Insights Blog

Type to search articles.